Nu-Med Plus (NUMD) Enterprise Value Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67.72% |
| Sep 30, 2025 | 42.69% |
| Jun 30, 2025 | 32.38% |
| Mar 31, 2025 | 33.56% |
| Dec 31, 2024 | 19.64% |
| Sep 30, 2024 | 37.34% |
| Jun 30, 2024 | 23.76% |
| Mar 31, 2024 | 22.86% |
| Dec 31, 2023 | 47.31% |
| Sep 30, 2023 | 41.95% |
| Jun 30, 2023 | 36.42% |
| Mar 31, 2023 | 28.07% |
| Dec 31, 2022 | 26.92% |
| Sep 30, 2022 | 72.64% |
| Mar 31, 2022 | 61.89% |
| Dec 31, 2021 | 1.28% |
| Sep 30, 2021 | -87.25% |
| Jun 30, 2021 | -14.00% |
| Mar 31, 2021 | -9.71% |
| Dec 31, 2020 | -43.57% |
| Sep 30, 2020 | -172.14% |
| Jun 30, 2020 | 10.63% |
| Mar 31, 2020 | -7.14% |
| Dec 31, 2019 | 33.94% |
| Sep 30, 2019 | 5.76% |
| Jun 30, 2019 | 16.81% |
| Mar 31, 2019 | -24.60% |
| Dec 31, 2018 | -66.15% |
| Sep 30, 2018 | -82.38% |
| Jun 30, 2018 | -103.56% |
| Mar 31, 2018 | -136.58% |
| Dec 31, 2017 | -243.79% |
| Sep 30, 2017 | -366.63% |
| Jun 30, 2017 | -73.12% |
| Mar 31, 2017 | -39.88% |
| Dec 31, 2016 | -70.27% |